approved EB-2 (NIW)

Postdoctoral Scholar

Medical Immunology · Iran · 2023-01-21

Processing Time
53 days
Decision Date
2023-01-21
Location
Illinois
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on engineering and enhancing T lymphocytes to produce anti-tumoral proteins during radiotherapy to improve cancer treatment. This work involves employing advanced biotechnical tools and genetic manipulation techniques to uncover neurodegenerative mechanisms and develop novel therapies for cancer diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cancer, the second leading cause of death in the U.S., and provides innovative treatments.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 10 years of experience, a strong publication record with 363 citations, and has received NIH funding.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's expertise in oncology and immunology makes her work beneficial to the U.S. national interest.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.Sc. degree, 20 peer-reviewed journal articles (5 first-authored), and 363 citations. Additional evidence included 9 completed peer reviews for authoritative journals, 10 years of research experience, and 2 expert recommendation letters confirming the national importance of her NIH-funded work.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.

Research Scientist

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Oklahoma 33 days 2025-09-10
The petitioner proposes to develop advanced preclinical cancer models to evaluate the efficacy and immune responses of novel immunotherapies, including cancer vaccines and antibody-drug conjugates. This work focuses on optimizing rational combination strategies to improve clinical outcomes for patients with treatment-resistant and aggressive cancers. The endeavor aims to bridge the gap between laboratory discovery and clinical application to make therapies safer and more accessible.

Postdoctoral Researcher

Biotechnology · Mexico

WeGreened EB-2 (NIW) approved
Maryland 489 days 2022-08-22
The petitioner proposes to develop a highly quantitative understanding of the interactions between cancer cells and the immune system. He utilizes high-resolution microscopy, high-throughput flow cytometry, and mathematical modeling to design personalized cancer immunotherapies that are more effective than current treatments.

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-01-21.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 53 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist